Business Context and Reporting Period
Lightbridge Corporation’s Form 10-K covers the fiscal year ended December 31, 2013, with 2012 as the comparable year. The company develops metallic nuclear-fuel technology and provides nuclear consulting and strategic advisory services. In 2013, all reported revenue came from consulting; the fuel technology business remained in research and development.
Financial Performance and Position
| Metric | 2013 | 2012 |
|---|---|---|
| Revenue | $1.901 million | $3.678 million |
| Gross profit / margin | $0.791 million / 41.6% | $1.411 million / 38.4% |
| Research and development expense | $2.028 million | $2.065 million |
| General and administrative expense | $3.617 million | $3.841 million |
| Operating loss | $(4.853) million | $(4.495) million |
| Net loss | $(4.865) million; $(0.37) per share | $(4.057) million; $(0.32) per share |
| Operating cash flow | $(3.916) million | $(5.053) million |
Revenue declined about 48%, largely due to reduced FANR work (approximately $1.6 million lower) and reduced ENEC work (approximately $0.2 million lower). Lower consulting costs and less use of outside consultants improved gross margin, but lower revenue and a sharp reduction in investment income contributed to a larger net loss.
At year-end, cash and cash equivalents were $3.673 million, marketable securities $0.016 million, and restricted cash $0.555 million. Working capital was approximately $4.5 million; current liabilities were $0.477 million. The company reported no debt or credit lines. Operating cash shortfall was estimated at about $300,000 per month. Management expected current working capital to fund operations for 12 months, while a note estimated funding through early 2015; both estimates depend on spending and new capital or revenue.
Net cash provided by financing was $3.957 million, mainly net proceeds from an October 2013 registered offering. The offering issued 2.5 million shares and warrants for 1.25 million shares. Common shares outstanding were 15.057 million at year-end and 15.064 million as of March 19, 2014.
Material Changes, Outlook and Risks
- Approximately 95% of 2013 revenue came from ENEC and FANR in the UAE, compared with 98% in 2012. Their contracts were extended through 2015 and December 31, 2014, respectively, but future work and billings depend on agreed project plans.
- Management expected to spend $3–4 million on fuel research and development over the following 12–15 months, versus approximately $2.0 million in 2013. It planned to seek equity, strategic investment, and new consulting work; proposals were pending, and management could not determine whether or when they would be awarded.
- The fuel remains untested in a commercial reactor. The filing projected fabrication samples and testing in 2015–2020, a pilot-scale facility in 2017–2018, commercial-reactor lead test assembly operation in 2020–2021, and potential first commercial reload qualification in 2023–2024. These are estimates, not commitments.
- Management’s stated technical potential includes up to 10% more power with a 24-month cycle in existing PWRs, up to 17% more power with an 18-month cycle, and up to 30% in new-build PWRs. These claims depend on development, testing, licensing, fabrication and customer adoption.
- In October 2013, Lightbridge and Babcock & Wilcox Nuclear Energy signed an MOU to explore a pilot-scale fuel fabrication facility. A post-year-end Lloyd’s Register subcontract for KHNP work provided for a maximum contract price of $400,000, inclusive of expenses and taxes, for work from February 2014 through February 2015.
- Key risks include financing needs, dependence on a small number of consulting clients, unproven fuel performance and commercialization, nuclear regulatory and export approvals, reliance on Russian partners and facilities, and public and market opposition to nuclear power. The DOE Part 810 export authorization and commercial arrangements with Russian entities remained relevant dependencies.
- The company reported effective disclosure controls and internal control over financial reporting as of year-end. The independent auditor issued an unqualified opinion on the consolidated financial statements.
Important Facts for Investors to Verify
- Whether new consulting contracts or strategic fuel-partner agreements were secured, and whether they provide meaningful cash or development funding.
- Actual cash burn, spending against the stated $3–4 million R&D plan, and the resulting funding runway; the filing’s runway estimates differ in wording.
- Progress on DOE export authorization, Russian and domestic development agreements, fuel fabrication, irradiation testing, and licensing milestones.
- Revenue concentration and the level of future work authorized under the ENEC and FANR contracts; confirm the timing and economics of the KHNP subcontract.
- Potential dilution from outstanding warrants and options, including the 1.25 million warrants issued in the October 2013 offering.